These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2686770)

  • 41. [Etiology of erythema migrans disease and Lyme disease. Review and results of personal study].
    Neubert U
    Hautarzt; 1984 Nov; 35(11):563-70. PubMed ID: 6519987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Procalcitonin levels in patients with Lyme borreliosis.
    Lotric-Furlan S; Maraspin-Carman V; Cimperman J; Ogrinc K; Stopar T; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):530-2. PubMed ID: 12422595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical spectrum of skin manifestations of Lyme borreliosis in 204 children in Austria.
    Glatz M; Resinger A; Semmelweis K; Ambros-Rudolph CM; Müllegger RR
    Acta Derm Venereol; 2015 May; 95(5):565-71. PubMed ID: 25366035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Dermatological aspects of Lyme borreliosis].
    Lipsker D
    Med Mal Infect; 2007; 37(7-8):540-7. PubMed ID: 17391884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early and late cutaneous manifestations in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme borreliosis).
    Asbrink E; Hovmark A
    Ann N Y Acad Sci; 1988; 539():4-15. PubMed ID: 3056204
    [No Abstract]   [Full Text] [Related]  

  • 46. Joint and bone involvement in Swedish patients with Ixodes ricinus-borne Borrelia infection.
    Hovmark A; Asbrink E; Olsson I
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec; 263(1-2):275-84. PubMed ID: 3577487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Multiple neurologic manifestations of Borrelia burgdorferi infection].
    Dupuis MJ
    Rev Neurol (Paris); 1988; 144(12):765-75. PubMed ID: 3070690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of the frequency of different Borrelia burgdorferi sensu lato species in patients with Lyme borreliosis from north-east Poland by studying preferential serologic response and DNA isolates.
    Grygorczuk S; Péter O; Kondrusik M; Moniuszko A; Zajkowska J; Dunaj J; Żukiewicz-Sobczak W; Pancewicz S
    Ann Agric Environ Med; 2013; 20(1):21-9. PubMed ID: 23540208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lyme borreliosis.
    Stanek G; Strle F
    Lancet; 2003 Nov; 362(9396):1639-47. PubMed ID: 14630446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Acrodermatitis chronica atrophicans: late manifestation of Lyme borreliosis].
    Krol CG; van der Geer S; Thio HB; Janssen MJ; Jonkers G
    Ned Tijdschr Geneeskd; 2010; 154():A2012. PubMed ID: 20699042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lyme borreliosis.
    Scarpa C; Trevisan G; Stinco G
    Dermatol Clin; 1994 Oct; 12(4):669-85. PubMed ID: 7805296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans.
    Weber K; Preac-Mursic V; Neubert U; Thurmayr R; Herzer P; Wilske B; Schierz G; Marget W
    Ann N Y Acad Sci; 1988; 539():324-45. PubMed ID: 3056202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Serologic diagnosis of Lyme disease in patients with undifferentiated arthritis. Diagnostic problems].
    Rodríguez-Moreno J; Casanova Rituerto A; Fiter J; Alcaide Fernández de Vega F; Contreras M; Domínguez Luzón MA
    Med Clin (Barc); 1992 Dec; 99(19):732-4. PubMed ID: 1460939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Lymphocyte proliferation test in cutaneous manifestations of Lyme borreliosis].
    Breier F; Klade H; Stanek G
    Wien Med Wochenschr; 1995; 145(7-8):170-3. PubMed ID: 7610666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Lyme disease acrodermitis chronica atrophicans: misleading vascular signs].
    Blaise S; Fiandrino G; Satger B; Carpentier PH
    J Mal Vasc; 2014 May; 39(3):212-5. PubMed ID: 24698204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of adequate versus inadequate treatment of cutaneous manifestations of Lyme borreliosis on the incidence of late complications and late serologic status.
    Plörer A; Sepp N; Schmutzhard E; Krabichler S; Trobos S; Schauer G; Pahl C; Stöffler G; Fritsch P
    J Invest Dermatol; 1993 Feb; 100(2):103-9. PubMed ID: 8429231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gender disparity between cutaneous and non-cutaneous manifestations of Lyme borreliosis.
    Strle F; Wormser GP; Mead P; Dhaduvai K; Longo MV; Adenikinju O; Soman S; Tefera Y; Maraspin V; Lotrič-Furlan S; Ogrinc K; Cimperman J; Ružić-Sabljić E; Stupica D
    PLoS One; 2013; 8(5):e64110. PubMed ID: 23737968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lyme borreliosis: aspects of tick-borne Borrelia burgdorferi infection from a dermatologic viewpoint.
    Asbrink E; Hovmark A
    Semin Dermatol; 1990 Dec; 9(4):277-91. PubMed ID: 2285572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer.
    Asbrink E; Hovmark A; Hederstedt B
    Acta Derm Venereol; 1984; 64(6):506-12. PubMed ID: 6084922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lyme borreliosis and multiple sclerosis.
    Schmutzhard E
    Biomed Pharmacother; 1989; 43(6):415-9. PubMed ID: 2686768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.